
On 1 June 2022, it was announced that the Tern Directors and Pires Directors had reached agreement on the terms of a recommended all-share offer by Tern..
Diverse Income Trust plc (LON:DIVI) invests primarily in quoted or traded UK companies with a wide range of market capitalisations, but a long-term bias toward small and..
CLO income fund Volta Finance Ltd (LON:VTA / LON:VTAS) is the topic of conversation when Mark Thomas, Analyst at Hardman & Co joins DirectorsTalk Interviews. Mark..
Cizzle Biotechnology plc (LON:CIZ), focused on cancer diagnostics, was spun out of the University of York to exploit the biomarker, variant CIZ1b, for the early detection..
Fidelity China Special Situations plc (LON:FCSS) is the topic of conversation when Hardman and Co’s Analyst Mark Thomas caught up with DirectorsTalk for an exclusive interview...
The Board of HICL Infrastructure PLC (LON:HICL) has announced that the Company has raised gross proceeds of £160.0m through the issue of 94,674,560 new ordinary shares..
The Board of LXi REIT plc (LON:LXI), the specialist inflation-protected very long income REIT, has announced that Jan Etherden, Non-Executive Director of the Company, will retire..
DCC plc (LON:DCC), the leading international sales, marketing and support services group, has issued this update in advance of the Company’s AGM to be held in..
Kenmare Resources plc (LON:KMR) was the topic of conversation when DirectorsTalk caught up with Davy Research Analyst Colin Grant. Q1. What are the highlights from Kenmare’s..
Burberry Group plc (LON:BRBY) has announced its first quarter trading update. “Our performance in the quarter continued to be impacted by lockdowns in Mainland China but..
N4 Pharma Plc (LON:N4P), the specialist pharmaceutical company developing Nuvec®, a novel delivery system for cancer treatments and vaccines, has announced a further update on its..
TomCo Energy plc (LON:TOM), the US operating oil development group focused on using innovative technology to unlock unconventional hydrocarbon resources, has announced that the Company’s wholly..
– Phase I VLP Peanut PROTECT trial incorporating ground-breaking VLP technology proceeding as planned with site initiation visits imminent – Pivotal Phase III Grass MATA MPL trial..









